Patel Naimish bought CRSP
October 3, 2025 · Form 4 insider transaction
Patel Naimish bought 16,500 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,500
Price
$0.00
Total value
N/A
InsiderPatel Naimish
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 3, 2025
Filing dateOctober 3, 2025
Shares owned after16,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025.